Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Brixton Biosciences in the transaction.Brixton Biosciences, a clinical stage life sciences company, announced it has raised $33 million…
Brixton Biosciences’ $33 Million Series B Financing Round
![](https://globallegalchronicle.com/wp-content/uploads/2024/05/brixton-biosciences-33-million-series-b-financing-round_664ef868910b8.jpeg)